Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study

Fig. 2

Hazard ratio for incident cardiovascular disease (CVD) in patients with type 2 diabetes classified as normal (blue), sarcopenia (green), obesity (orange), and sarcopenic obesity (purple) according to android to gynoid ratio (A/G ratio) (a univariate model; b multivariate model), android fat mass (c univariate model; d multivariate model), percentage of body fat (%BF) (e univariate model; f multivariate model), or body mass index (BMI) (g univariate model; h multivariate model), respectively. The multivariate models included high-density lipoprotein cholesterol, HbA1c, estimated glomerular filtration ratio, the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, the use of dipeptidyl peptidase 4 inhibitors, and history of CVD as covariates. *p < 0.05 vs patients classified as normal by the Cox regression analysis

Back to article page